Erasca reported favorable safety and tolerability with no dose-limiting toxicities and predominantly low-grade adverse events across all dose levels. Initial Phase 1 monotherapy data for ERAS-0015 are ...
Serial murder is neither a new phenomenon, nor is it uniquely American,” reads a public report from the FBI on the subject.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback